<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, clinical manifestations and outcomes of this mild COVID‐19 patient with haemophilia were similar to that in non‐haemophilic individuals. Mild infection of SARS‐CoV‐2 may not increase the occurrence of bleeding events in haemophilic cases. And such cases may benefit from administration of replacement factors at the onset of COVID‐19. Despite the insufficient clinical investigation of these cases, the success of this case reveals that home management may be possible for them.</p>
